2017 Q1 Form 10-Q Financial Statement

#000119312517165829 Filed on May 10, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q1
Revenue $21.29M $16.51M
YoY Change 28.95% 19.33%
Cost Of Revenue $1.696M $1.628M
YoY Change 4.18% 37.38%
Gross Profit $19.59M $14.88M
YoY Change 31.66% 17.64%
Gross Profit Margin 92.03% 90.14%
Selling, General & Admin $5.063M $4.835M
YoY Change 4.72% 9.94%
% of Gross Profit 25.84% 32.49%
Research & Development $9.873M $7.914M
YoY Change 24.75% 7.48%
% of Gross Profit 50.4% 53.19%
Depreciation & Amortization $443.0K $298.0K
YoY Change 48.66% 16.86%
% of Gross Profit 2.26% 2.0%
Operating Expenses $15.25M $13.06M
YoY Change 16.75% 8.04%
Operating Profit $4.346M $1.822M
YoY Change 138.53% 223.62%
Interest Expense $570.0K $440.0K
YoY Change 29.55% -1566.67%
% of Operating Profit 13.12% 24.15%
Other Income/Expense, Net
YoY Change
Pretax Income $4.917M $2.263M
YoY Change 117.28% 322.2%
Income Tax $810.0K $463.0K
% Of Pretax Income 16.47% 20.46%
Net Earnings $4.107M $1.800M
YoY Change 128.17% 270.37%
Net Earnings / Revenue 19.29% 10.9%
Basic Earnings Per Share $0.19
Diluted Earnings Per Share $0.19 $86.00K
COMMON SHARES
Basic Shares Outstanding 21.40M shares 20.52M shares
Diluted Shares Outstanding 22.19M shares 20.93M shares

Balance Sheet

Concept 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $76.88M $106.2M
YoY Change -27.61% 19.46%
Cash & Equivalents $12.62M $11.32M
Short-Term Investments $64.26M $94.90M
Other Short-Term Assets $4.600M $2.900M
YoY Change 58.62% -60.27%
Inventory
Prepaid Expenses
Receivables $13.78M $6.709M
Other Receivables $0.00 $0.00
Total Short-Term Assets $132.0M $115.9M
YoY Change 13.97% 7.63%
LONG-TERM ASSETS
Property, Plant & Equipment $5.826M $3.844M
YoY Change 51.56% 40.96%
Goodwill $46.61M $46.61M
YoY Change 0.0% 0.0%
Intangibles $3.905M
YoY Change -24.72%
Long-Term Investments $53.50M $34.40M
YoY Change 55.52% -16.1%
Other Assets $3.575M $3.642M
YoY Change -1.84% 101.66%
Total Long-Term Assets $119.6M $98.36M
YoY Change 21.56% -4.98%
TOTAL ASSETS
Total Short-Term Assets $132.0M $115.9M
Total Long-Term Assets $119.6M $98.36M
Total Assets $251.6M $214.2M
YoY Change 17.45% 1.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $400.0K $1.400M
YoY Change -71.43% 7.69%
Accrued Expenses $3.869M $4.410M
YoY Change -12.27% 36.66%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $22.56M $18.78M
YoY Change 20.12% -3.98%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $8.900M $8.200M
YoY Change 8.54% 7.89%
Total Long-Term Liabilities $8.900M $8.200M
YoY Change 8.54% -7.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $22.56M $18.78M
Total Long-Term Liabilities $8.900M $8.200M
Total Liabilities $31.40M $26.90M
YoY Change 16.73% -5.31%
SHAREHOLDERS EQUITY
Retained Earnings $42.95M $31.16M
YoY Change 37.82% 41.14%
Common Stock $212.7M $209.9M
YoY Change 1.31% -0.19%
Preferred Stock
YoY Change
Treasury Stock (at cost) $35.13M $53.78M
YoY Change -34.68% 9.05%
Treasury Stock Shares 2.065M shares 3.161M shares
Shareholders Equity $220.2M $187.3M
YoY Change
Total Liabilities & Shareholders Equity $251.6M $214.2M
YoY Change 17.45% 1.45%

Cashflow Statement

Concept 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income $4.107M $1.800M
YoY Change 128.17% 270.37%
Depreciation, Depletion And Amortization $443.0K $298.0K
YoY Change 48.66% 16.86%
Cash From Operating Activities $6.290M $240.0K
YoY Change 2520.83% -135.82%
INVESTING ACTIVITIES
Capital Expenditures $1.435M $411.0K
YoY Change 249.15% 9.02%
Acquisitions
YoY Change
Other Investing Activities -$13.02M -$4.940M
YoY Change 163.56% 637.31%
Cash From Investing Activities -$14.46M -$5.350M
YoY Change 170.28% 414.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $3.417M
YoY Change 78.25%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.360M -2.510M
YoY Change -194.02% 434.04%
NET CHANGE
Cash From Operating Activities 6.290M 240.0K
Cash From Investing Activities -14.46M -5.350M
Cash From Financing Activities 2.360M -2.510M
Net Change In Cash -5.810M -7.620M
YoY Change -23.75% 249.54%
FREE CASH FLOW
Cash From Operating Activities $6.290M $240.0K
Capital Expenditures $1.435M $411.0K
Free Cash Flow $4.855M -$171.0K
YoY Change -2939.18% -83.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21553156 shares
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11315000
CY2017Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
2064597 shares
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21530563 shares
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23595160 shares
CY2017Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
311056 shares
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
42946000
CY2017Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
251609000
CY2017Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12023000
CY2017Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6283000
CY2017Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-289000
CY2017Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
381000
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
220178000
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
22000
CY2017Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
212632000
CY2017Q1 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
8875000
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
22556000
CY2017Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
35000
CY2017Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3869000
CY2017Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
407000
CY2017Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
22000
CY2017Q1 us-gaap Assets Current
AssetsCurrent
132048000
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
53062000
CY2017Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
46486000
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5826000
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12621000
CY2017Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
2572000
CY2017Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13777000
CY2017Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
119561000
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
52707000
CY2017Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
64255000
CY2017Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
385000
CY2017Q1 us-gaap Assets
Assets
251609000
CY2017Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
64627000
CY2017Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
4397000
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
11565000
CY2017Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
11548000
CY2017Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2669000
CY2017Q1 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
42000
CY2017Q1 us-gaap Goodwill
Goodwill
46612000
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3575000
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4596000
CY2017Q1 us-gaap Treasury Stock Value
TreasuryStockValue
35133000
CY2017Q1 ceva Accrued Severance Pay Noncurrent
AccruedSeverancePayNoncurrent
8875000
CY2017Q1 ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisableWeightedAverageExercisePrice
19.64
CY2017Q1 ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageExercisePrice
19.75
CY2017Q1 ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber
1271541 shares
CY2017Q1 ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisableNumber
849332 shares
CY2017Q1 ceva Available For Sale Matures Within One Year Gross Unrealized Gains
AvailableForSaleMaturesWithinOneYearGrossUnrealizedGains
6000
CY2017Q1 ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisableAggregateIntrinsicValue
13466000
CY2017Q1 ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingAggregateIntrinsicValue
20031000
CY2017Q1 ceva Available For Sale Matures Within One Year Gross Unrealized Loss
AvailableForSaleMaturesWithinOneYearGrossUnrealizedLoss
23000
CY2017Q1 ceva Severance Pay Fund Noncurrent
SeverancePayFundNoncurrent
8335000
CY2017Q1 ceva Short Term Bank Deposits
ShortTermBankDeposits
36799000
CY2017Q1 ceva Long Term Bank Deposits
LongTermBankDeposits
49972000
CY2017Q1 ceva Available For Sale Matures After One Year Through Five Years Gross Unrealized Gains
AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains
29000
CY2017Q1 ceva Available For Sale Matures After One Year Through Five Years Gross Unrealized Loss
AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss
384000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18909000
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2321660 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21273500 shares
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23595160 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
39431000
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
242495000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11751000
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6258000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-497000
CY2016Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
571000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
211551000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
21000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
212103000
CY2016Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
8349000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22595000
CY2016Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
7000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4015000
CY2016Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
586000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
29000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
144712000
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
52991000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
48663000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4805000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18401000
CY2016Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
2252000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15044000
CY2016Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
97783000
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
52423000
CY2016Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
61868000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
557000
CY2016Q4 us-gaap Assets
Assets
242495000
CY2016Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
62447000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
4875000
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
9456000
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
9445000
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2978000
CY2016Q4 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
6000
CY2016Q4 us-gaap Goodwill
Goodwill
46612000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3218000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3152000
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
39507000
CY2016Q4 ceva Accrued Severance Pay Noncurrent
AccruedSeverancePayNoncurrent
8349000
CY2016Q4 ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageExercisePrice
19.76
CY2016Q4 ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber
1455908 shares
CY2016Q4 ceva Available For Sale Matures Within One Year Gross Unrealized Gains
AvailableForSaleMaturesWithinOneYearGrossUnrealizedGains
4000
CY2016Q4 ceva Available For Sale Matures Within One Year Gross Unrealized Loss
AvailableForSaleMaturesWithinOneYearGrossUnrealizedLoss
15000
CY2016Q4 ceva Long Term Bank Deposits
LongTermBankDeposits
29977000
CY2016Q4 ceva Available For Sale Matures After One Year Through Five Years Gross Unrealized Gains
AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains
3000
CY2016Q4 ceva Severance Pay Fund Noncurrent
SeverancePayFundNoncurrent
7941000
CY2016Q4 ceva Short Term Bank Deposits
ShortTermBankDeposits
46247000
CY2016Q4 ceva Available For Sale Matures After One Year Through Five Years Gross Unrealized Loss
AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss
571000
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
104000 shares
CY2017Q1 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="break-inside: avoid"> <td valign="top" width="12%" align="left"><b>NOTE&#xA0;11:</b></td> <td valign="top" align="left"><b>IMPACT OF RECENTLY ISSUED ACCOUNTING STANDARDS NOT YET ADOPTED</b></td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; MARGIN-LEFT: 99px; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; font-variant-ligatures: normal; font-variant-caps: normal"> <b>Revenue recognition</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; -webkit-text-stroke-width: 0px; font-variant-ligatures: normal; font-variant-caps: normal"> In May 2014, the FASB issued a new standard related to revenue recognition. Under the new standard, revenue is recognized when a customer obtains control of promised goods or services and is recognized in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The FASB has recently issued several amendments to the standard, including clarification on identifying performance obligations.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; -webkit-text-stroke-width: 0px; font-variant-ligatures: normal; font-variant-caps: normal"> The guidance permits two methods of modification: retrospectively to each prior reporting period presented (full retrospective method), or retrospectively with the cumulative effect of initially applying the guidance recognized at the date of initial application (the cumulative&#xA0;<font style="WHITE-SPACE: nowrap">catch-up</font>&#xA0;transition method). The Company currently anticipates adopting the standard using the modified retrospective method rather than full retrospective method.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; -webkit-text-stroke-width: 0px; font-variant-ligatures: normal; font-variant-caps: normal"> The new standard will be effective for the Company beginning January&#xA0;1, 2018, but adoption as of the original effective date of January&#xA0;1, 2017 is permitted. The Company will adopt the new standard as of January&#xA0;1, 2018.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; -webkit-text-stroke-width: 0px; font-variant-ligatures: normal; font-variant-caps: normal"> The Company has made progress toward completing its evaluation of the potential changes from adopting this new standard on its financial reporting and disclosures. The Company has evaluated the impact of the standard on a majority of its revenue streams and associated contracts. The Company expects to complete the contract evaluations and validate the results during the first half of 2017. The Company formed an implementation work group and expects to complete the evaluation of the impact of the accounting and disclosure changes on its business processes, controls and systems throughout 2017, design any changes to such business processes, controls and systems, and implement the changes before the end of 2017.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; -webkit-text-stroke-width: 0px; font-variant-ligatures: normal; font-variant-caps: normal"> Under the new standard, an entity recognizes revenue when or as it satisfies a performance obligation by transferring IP license or services to the customer, either at a point in time or over time. The Company expects to continue to recognize most of its revenue at a point in time upon delivery of its products. The Company expects to recognize revenue over time on significant license customization contracts that are covered by contract accounting standards using cost inputs to measure progress toward completion of its performance obligations, which is similar to the current method.</p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; font-variant-ligatures: normal; font-variant-caps: normal"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; -webkit-text-stroke-width: 0px; font-variant-ligatures: normal; font-variant-caps: normal"> Based on its current analysis, the most significant effect on the Company, if any, will be related to certain deliverables that may be considered as distinct performance obligations separate from other performance obligations and will be measured using the relative standalone selling price basis.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; -webkit-text-stroke-width: 0px; font-variant-ligatures: normal; font-variant-caps: normal"> In addition, incremental costs that are related to sales from contracts signed during the period would require capitalization. The Company also will consider if there is a significant financing component if the time between payment and performance is more than one year.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; -webkit-text-stroke-width: 0px; font-variant-ligatures: normal; font-variant-caps: normal"> The Company continues to assess all potential impacts under the new revenues standard.</p> </div>
CY2017Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q1 dei Document Type
DocumentType
10-Q
CY2017Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001173489
CY2017Q1 us-gaap Nature Of Operations
NatureOfOperations
<div> <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr style="page-break-inside:avoid"> <td width="12%" valign="top" align="left"><b>NOTE&#xA0;1:</b></td> <td align="left" valign="top"><b>BUSINESS</b></td> </tr> </table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> The financial information in this quarterly report includes the results of CEVA, Inc. and its subsidiaries (the &#x201C;Company&#x201D; or &#x201C;CEVA&#x201D;).</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"> CEVA licenses a family of signal processing IPs, including programmable DSP cores and application-specific platforms for advanced imaging, computer vision and deep learning for many camera-enabled devices, sound, voice and audio, as well as long and short range wireless technologies for <font style="white-space:nowrap">LTE/LTE-A/5G</font> baseband processing in handsets and infrastructure, short range wireless for <font style="white-space:nowrap">Wi-Fi</font> and Bluetooth IPs, and wired interface for storage, Serial ATA (SATA) and Serial Attached SCSI (SAS).</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> CEVA&#x2019;s technologies are licensed to leading semiconductor and original equipment manufacturer (OEM) companies in the form of intellectual property (IP). These companies design, manufacture, market and sell application-specific integrated circuits (&#x201C;ASICs&#x201D;) and application-specific standard products (&#x201C;ASSPs&#x201D;) based on CEVA&#x2019;s technology to wireless, consumer electronics and automotive companies for incorporation into a wide variety of end products.</p> </div>
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
6289000
CY2017Q1 dei Trading Symbol
TradingSymbol
CEVA
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22187000 shares
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21398000 shares
CY2017Q1 dei Amendment Flag
AmendmentFlag
false
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
4346000
CY2017Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2017Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q1 dei Document Period End Date
DocumentPeriodEndDate
2017-03-31
CY2017Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2017Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
789000 shares
CY2017Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 18pt"> <b><i>Use of Estimates</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The preparation of the interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company&#x2019;s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates of the interim condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p> </div>
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.19
CY2017Q1 dei Entity Registrant Name
EntityRegistrantName
CEVA INC
CY2017Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 Segment
CY2017Q1 us-gaap Revenues
Revenues
21287000
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1435000
CY2017Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
207000
CY2017Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
311000
CY2017Q1 us-gaap Investment Income Net
InvestmentIncomeNet
571000
CY2017Q1 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
-38000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
4107000
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1266000
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4315000
CY2017Q1 us-gaap Royalty Revenue
RoyaltyRevenue
11752000
CY2017Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
10696000
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
169000
CY2017Q1 us-gaap Licenses Revenue
LicensesRevenue
9535000
CY2017Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1280000
CY2017Q1 us-gaap Gross Profit
GrossProfit
19591000
CY2017Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-27000
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
182000
CY2017Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
208000
CY2017Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
243000
CY2017Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
36000
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1738000
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4917000
CY2017Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
29000
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1949000
CY2017Q1 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
38000
CY2017Q1 us-gaap Depreciation
Depreciation
443000
CY2017Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
25000
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
810000
CY2017Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-220000
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-14457000
CY2017Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2363000
CY2017Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
5931000
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1949000
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
25000
CY2017Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
103000
CY2017Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2938000
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2125000
CY2017Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-11000
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2363000
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9873000
CY2017Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
309000
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5780000
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
1696000
CY2017Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-140000
CY2017Q1 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
304000
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
15245000
CY2017Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-38000
CY2017Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
146000
CY2017Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
35000
CY2017Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
2243000
CY2017Q1 ceva Investment In Bank Deposits
InvestmentInBankDeposits
21000000
CY2017Q1 ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercises In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriod
178458 shares
CY2017Q1 ceva Increase Decrease In Accrued Interest On Bank Deposits
IncreaseDecreaseInAccruedInterestOnBankDeposits
-114000
CY2017Q1 ceva Increase Decrease In Accrued Severance Pay Net
IncreaseDecreaseInAccruedSeverancePayNet
108000
CY2017Q1 ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
17.95
CY2017Q1 ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsForfeituresInPeriod
5909 shares
CY2017Q1 ceva Proceeds From Bank Deposits
ProceedsFromBankDeposits
10500000
CY2017Q1 ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsGrantsInPeriod
0 shares
CY2017Q1 ceva Increase Decrease In Deferred Tax Net
IncreaseDecreaseInDeferredTaxNet
-355000
CY2017Q1 ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerms
P4Y8M12D
CY2017Q1 ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Grant In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsGrantInPeriodWeightedAverageExercisePrice
0
CY2017Q1 ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercisable Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerms
P3Y8M12D
CY2017Q1 ceva Share Based Compensation Arrangements By Share Based Payment Award Options And Stock Appreciation Rights Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice
19.92
CY2017Q1 ceva Increase Decrease In Accrued Salaries And Related Expenses
IncreaseDecreaseInAccruedSalariesAndRelatedExpenses
-63000
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
755182 shares
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
236000
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20926000 shares
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20520000 shares
CY2016Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
180013 shares
CY2016Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
406000 shares
CY2016Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
18.98
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.09
CY2016Q1 us-gaap Revenues
Revenues
16508000
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
411000
CY2016Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3417000
CY2016Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
253000
CY2016Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
405000
CY2016Q1 us-gaap Investment Income Net
InvestmentIncomeNet
441000
CY2016Q1 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
-30000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1822000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
1800000
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2637000
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2208000
CY2016Q1 us-gaap Royalty Revenue
RoyaltyRevenue
7858000
CY2016Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
15434000
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
223000
CY2016Q1 us-gaap Licenses Revenue
LicensesRevenue
8650000
CY2016Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
311000
CY2016Q1 us-gaap Gross Profit
GrossProfit
14880000
CY2016Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
6000
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
235000
CY2016Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
408000
CY2016Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
463000
CY2016Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
210000
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
462000
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2263000
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1474000
CY2016Q1 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
30000
CY2016Q1 us-gaap Depreciation
Depreciation
298000
CY2016Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
24000
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
463000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
716000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-5349000
CY2016Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
912000
CY2016Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
6408000
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1474000
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1334000
CY2016Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-3000
CY2016Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2845000
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1990000
CY2016Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
293000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-2505000
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7914000
CY2016Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
309000
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7594000
CY2016Q1 us-gaap Cost Of Revenue
CostOfRevenue
1628000
CY2016Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
467000
CY2016Q1 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
249000
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
13058000
CY2016Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-30000
CY2016Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
25000
CY2016Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
55000
CY2016Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
2975000
CY2016Q1 ceva Increase Decrease In Accrued Interest On Bank Deposits
IncreaseDecreaseInAccruedInterestOnBankDeposits
272000
CY2016Q1 ceva Treasury Stock Value Acquired Weighted Average Method
TreasuryStockValueAcquiredWeightedAverageMethod
3417
CY2016Q1 ceva Increase Decrease In Accrued Severance Pay Net
IncreaseDecreaseInAccruedSeverancePayNet
206000
CY2016Q1 ceva Proceeds From Bank Deposits
ProceedsFromBankDeposits
1113000
CY2016Q1 ceva Increase Decrease In Deferred Tax Net
IncreaseDecreaseInDeferredTaxNet
-355000
CY2016Q1 ceva Increase Decrease In Accrued Salaries And Related Expenses
IncreaseDecreaseInAccruedSalariesAndRelatedExpenses
540000

Files In Submission

Name View Source Status
0001193125-17-165829-index-headers.html Edgar Link pending
0001193125-17-165829-index.html Edgar Link pending
0001193125-17-165829.txt Edgar Link pending
0001193125-17-165829-xbrl.zip Edgar Link pending
ceva-20170331.xml Edgar Link completed
ceva-20170331.xsd Edgar Link pending
ceva-20170331_cal.xml Edgar Link unprocessable
ceva-20170331_def.xml Edgar Link unprocessable
ceva-20170331_lab.xml Edgar Link unprocessable
ceva-20170331_pre.xml Edgar Link unprocessable
d373675d10q.htm Edgar Link pending
d373675dex311.htm Edgar Link pending
d373675dex312.htm Edgar Link pending
d373675dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending